“With this rebranding, we aim to show that we are constantly changing to match the world’s shift toward CBD and that our products are meant for use by all consumers while maintaining our high quality.”Additionally, HempMeds® is in the process of selecting highly respected professionals for its Medical Advisory Board, which will aid in advising the Company’s expansion.View the updated HempMeds® website at https://hempmedspx.com/ and shop the entire line of HempMeds®’s newly rebranded products at https://hempmedspx.com/cbd-oil-products/.About HempMeds®Founded in 2012, HempMeds® was the first company to bring hemp-based cannabidiol (CBD) oil products to market in the U.S. As a subsidiary of Medical Marijuana, Inc., HempMeds is the exclusive distributor for premium brands including Real Scientific Hemp Oil™ and Dixie Botanicals®, and operates in all 50 states and 40 countries. The average price target is $128.35, with a high forecast of $200.00 and a low forecast of $68.00. This price target is based on 18 analysts offering 12 month price targets for Moderna in the last 3 months. When setting a price target estimate, an analyst is trying to determine what the OTC Stock is worth and where the price will be in a year from now. Medical Marijuana, Inc. (OTC Pink:MJNA) is the first publicly traded cannabis company in the United States. FORWARD-LOOKING DISCLAIMERThis press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. What stocks does MarketBeat like better than Medical Marijuana? Medical Marijuana Inc. analyst estimates, including MJNA earnings per share estimates and analyst recommendations. Source: FactSet, Indexes: Index quotes may be real-time or delayed as per exchange requirements; refer to time stamps for information on any delays. Change value during the period between open outcry settle and the commencement of the next day's trading is calculated as the difference between the last trade and the prior day's settle. Sources: FactSet, Tullett Prebon, Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. All rights reserved. Sources: FactSet, Dow Jones, Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. “We are confident that consumers will respond positively to the new HempMeds branding as we continue pushing the industry forward as have since founding the company to help trailblaze the CBD market many years ago.”The HempMeds® rebranding includes a new website, updated Company logos, new product formulations and refreshed packaging that aim to serve as more consumer-friendly, easy to understand and appeal to a wide audience. In depth view into MJNA (Medical Marijuana) stock including the latest price, news, dividend history, earnings information and financials. We use cookies and browser capability checks to help us deliver our online services, including to learn if you enabled Flash for video or ad blocking. All rights reserved. Source: FactSet, Markets Diary: Data on U.S. Overview page represent trading in all U.S. markets and updates until 8 p.m. See Closing Diaries table for 4 p.m. closing data. Medical Marijuana Inc stock rating and analysis - : a summary of key financial strength and profitability metrics. risk over market) , and overall volatility . Cronos Group Stock Price Forecast, CRON stock price prediction. View which stocks have been most impacted by COVID-19. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. Over the past Medical Marijuana's stock was trading at $0.0150 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Find real-time MJNA - Medical Marijuana Inc stock quotes, company profile, news and forecasts from CNN Business. “While our flagship RSHO products remain popular, we recognized it was time to expand alongside the industry and broaden our offerings as part of the company’s exciting new direction. Investors may trade in … The new products will expand the Company’s cannabinoid offerings and appeal to consumers’ changing demand.“After many years of fighting for broadened access to CBD around the globe, cannabinoids have finally been accepted into mainstream culture in the U.S. and other countries around the world,” said HempMeds® CEO Raul Elizalde. Medical Marijuana, Inc.’s headquarters is in San Diego, California, and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. View real-time stock prices and stock quotes for a full financial overview. Sources: FactSet, Dow Jones, Bonds: Bond quotes are updated in real-time. Their average twelve-month price target is $128.59, predicting that the stock has a possible upside of 10.60%. 2 years ago Two stocks that hope to become big winners in this hemp market are Medical Marijuana (NASDAQOTH: MJNA) and CV Sciences (NASDAQOTH: CVSI).) To learn more, please visit www.hempmedspx.com.About Medical Marijuana, Inc.We are a company of firsts®. Subsidiary has exclusive access to a "key" government owned patent. We are confident that consumers will be excited about our new CBG and CBN products.”Each 12-ounce bottle of HempMeds®’ RSHO® Calm Support is formulated to promote overall relaxation with 300 mg of CBN, 2,000 mg of CBD and 300 mg of Piperine, naturally derived from black pepper, to increase bioavailability. HempMeds® is the only company to have its CBD products listed in the Prescribers’ Digital Reference (PDR), the only company invited to speak to the World Health Organization and FDA on the benefits of CBD, and one of the first to be certified by the U.S. Hemp Authority. Lipper shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. This product is not intended to diagnose, treat, cure, or prevent any disease.LEGAL DISCLOSUREMedical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act.CONTACT:Public Relations Contact: Kathryn Brown Account Supervisor CMW Media P. 858-264-6600 kathryn@cmwmedia.com www.cmwmedia.comInvestor Relations Contact: P. (858) 283-4016 Investors@medicalmarijuanainc.comAttachment * MJNA. View the latest Medical Marijuana Inc. (MJNA) stock price, news, historical charts, analyst ratings and financial information from WSJ. Medical Marijuana, Inc.’s headquarters is in San Diego, California, and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com.To see Medical Marijuana, Inc.'s corporate video, click here.Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.'s shop. HempMeds® is the only company to have its CBD products listed in the Prescribers’ Digital Reference (PDR), the only company invited to speak to the World Health Organization and FDA on the benefits of CBD, and one of the first to be certified by the U.S. Hemp Authority. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. Medical Marijuana, Inc. MJNA Stock Message Board: price target? Will MJNA stock price grow / rise / go up? Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its pharmaceutical investment companies and partners including AXIM® Biotechnologies, Inc. and Neuropathix, Inc. Medical Marijuana, Inc. was named a top CBD producer by CNBC. Medical Marijuana Inc. stock price up 4.35% on Tuesday (Updated on January 05, 2021) Sell candidate since 2020-12-28 Gain 3.23% PDF The Medical Marijuana Inc. stock price gained 4.35% on the last trading day (Tuesday, 5th Jan 2021), rising from $0.02 to $0.02., and has now gained 3 days in a row. Medical Marijuana Inc (MJNA) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. MJNA is flat $0.00 from the previous closing price of $0.02 on volume of 8,676,814 shares. 12:23a U.S. Capitol takes on look of … FactSet (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. By using our website or by closing this message box, you agree to our use of browser capability checks, and to our use of cookies as described in our Cookie Policy. The change will be -92.244 %. Closing Stock Price USD 0.0409 As of Date September 1, 2015 One Year Performance -74.36% One Month Performance -17.87% Sources: CoinDesk (Bitcoin), Kraken (all other cryptocurrencies), Calendars and Economy: 'Actual' numbers are added to the table after economic reports are released. Medical Marijuana Inc (MJNA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Mutual Funds & ETFs: All of the mutual fund and ETF information contained in this display, with the exception of the current price and price history, was supplied by Lipper, A Refinitiv Company, subject to the following: Copyright © Refinitiv. Sources: FactSet, Dow Jones, ETF Movers: Includes ETFs & ETNs with volume of at least 50,000. MJNA | Complete Medical Marijuana Inc. stock news by MarketWatch. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its internal R&D and scientific team and its pharmaceutical investment companies and partners including AXIM® Biotechnologies, Inc. and Neuropathix, Inc. Medical Marijuana, Inc. was named a top CBD producer by CNBC. The average price target represents a 14.88% upside from the last price of $111.73. Medical Marijuana, Inc. Subsidiary HempMeds® Broadens Offerings to Include Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSUREThese statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.LEGAL DISCLOSUREMedical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). Fundamental company data and analyst estimates provided by FactSet.